Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 11, 2007, Pages 4101-4106

  Danielsson, Pernilla ^a   Janson, Annika ^a   Norgren, Svante ^a   Marcus, Claude ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE;

ADOLESCENT; ADULT; ARTICLE; BODY FAT; BODY MASS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FATIGUE; FEMALE; HUMAN; HYPOPITUITARISM; HYPOTHALAMUS; INSOMNIA; LOW DRUG DOSE; MALE; MOOD DISORDER; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; XEROSTOMIA;

EID: 35948962283     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0826     Document Type: Article

References (26)

1. Lobstein T, Baur L, Uauy R 2004 Obesity in children and young people: a crisis in public health. Obes Rev 5(Suppl 1):4-104
2. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S 2004 Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 350:2362-2374
3. Dietz WH, Robinson TN 2005 Clinical practice. Overweight children and adolescents. N Engl J Med 352:2100-2109
4. Lindgren AC, Barkeling B, Hagg A, Ritzen EM, Marcus C, Rossner S 2000 Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups. J Pediatr 137:50-55
5. Sorva R 1988 Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 77:587-592
6. Geffner M, Lundberg M, Koltowska-Haggstrom M, Abs R, Verhelst J, Erfurth EM, Kendall-Taylor P, Price DA, Jonsson P, Bakker B 2004 Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab 89:5435-5440
7. Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, Shine B, Turner HE, Wass JA 2005 Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf) 62:397-409
8. Farooqi IS, O'Rahilly S 2005 Monogenic obesity in humans. Annu Rev Med 56:443-458
9. Bray GA 1984 Syndromes of hypothalamic obesity in man. Pediatr Ann 13:525-536
10. Muller HL, Bruhnken G, Emser A, Faldum A, Etavard-Gorris N, Gebhardt U, Kolb R, Sorensen N 2005 Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma. Childs Nerv Syst 21:975-980
11. Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E 2004 Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46:220-229
12. Asp NG, Björntorp P, Britton M, Carlsson P, Kjellström T, Marcus C, Nerbrand C, Näslund I, Rössner S, Sjöström L, Östman J 2004 Treating and preventing obesity. In: Östman J, Britton M, Jonsson E, eds. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co.
13. Summerbell CD, Ashton V, Campbell KJ, Edmunds L, Kelly S, Waters E 2003 Interventions for treating obesity in children. Cochrane Database Syst Rev CD001872
14. Ryan DH, Kaiser P, Bray GA 1995 Sibutramine: a novel new agent for obesity treatment. Obes Res 3(Suppl 4):553S-559S
15. Berkowitz RI, Wadden TA, Tershakovec AM, Cronquist JL 2003 Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA 289:1805-1812
16. Godoy-Matos A, Carraro L, Vieira A, Oliveira J, Guedes EP, Mattos L, Rangel C, Moreira RO, Coutinho W, Appolinario JC 2005 Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study. J Clin Endocrinol Metab 90:1460-1465
17. Berkowitz RI, Fujioka K, Daniels SR, Hoppin AG, Owen S, Perry AC, Sothern MS, Renz CL, Pirner MA, Walch JK, Jasinsky O, Hewkin AC, Blakesley VA 2006 Effects of sibutramine treatment in obese adolescents: a randomized trial. Ann Intern Med 145:81-90
18. Daniels SR, Long B, Crow S, Styne D, Sothern M, Vargas-Rodriguez I, Harris L, Walch J, Jasinsky O, Cwik K, Hewkin A, Blakesley V 2007 Cardiovascular effects of sibutramine in the treatment of obese adolescents: results of a randomized, double-blind, placebo-controlled study. Pediatrics 120:e147-e157
19. Garcia-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvarez LM 2006 Use of sibutramine in obese Mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial. Clin Ther 28:770-782
20. Van Mil EG, Westerterp KR, Kester AD, Delemarre-van de Waal HA, Gerver WJ, Saris WH 2007 The effect of sibutramine on energy expenditure and body composition in obese adolescents. J Clin Endocrinol Metab 92:1409-1414
21. Rolland-Cachera MF, Sempe M, Guilloud-Bataille M, Patois E, Pequignot-Guggenbuhl F, Fautrad V 1982 Adiposity indices in children. Am J Clin Nutr 36:178-184
22. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH 2000 Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240-1243
23. Yanovski SZ, Yanovski JA 2002 Obesity. N Engl J Med 346:591-602
24. Jeanrenaud B 1985 An hypothesis on the etiology of obesity: dysfunction of the central nervous system as a primary cause. Diabetologia 28:502-513
25. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X 2003 Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88:2586-2592
26. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE 1999 Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 135:162-168